SPIRE Bioventures hosts CTA webinar with speakers Syed Hamdani, CEO at DNAmito and Hicham Jorio, Managing Partner at SPIRE Bioventures and Advisor at Arbor Vita
Friday, May 19th 2017 - SPIRE Bioventures was delighted to host its 4th webinar for the current cohort of the Canada Technology Accelerator for Health Sciences in the Bay Area. Syed Hamdani, CEO at DNAmito gave great insight and advice on howw to establish presence in the Bay Area for...
Stanford's Dr. Lau discussing the Typlit Platform
Dr. James Lau, Minimally invasive, laparoscopic and robotic surgeon at Stanford Hospital and Director of the Goodman Simulation Center discussing how Typlit aims to change the standard of care in cutting and ligation of tubular structures in the growing sector of Minimally invasive, Laparoscopic and Robotic surgery.
SPIRE Bioventures facilitates Spain and Portugal distribution agreement between DxNOW and CIMAB (Center of Male Infertility in Barcelona)
April 25th, 2017 -SPIRE Bioventures is delighted to announce that it has facilitated a distribution agreement between DxNow and CIMAB (Center of Male Infertility in Barcelona). CIMAB which is headquartered in Barcelona, Spain, will be distributing DxNow Fertile™ and Fertile Plus™ products in Spain and Portugal.